Literature DB >> 16287687

The severe acute respiratory syndrome (SARS).

Samson S Y Wong1, K Y Yuen.   

Abstract

The world was shocked in early 2003 when a pandemic of severe acute respiratory syndrome (SARS) was imminent. The outbreak of this novel disease, caused by a novel coronavirus (the SARS-coronavirus), hit hardest in the Asian Pacific region, though eventually it spread to five continents. The speed of the spread of the SARS epidemic was unprecedented due to the highly efficient intercontinental transportation. An international collaborative effort through the World Health Organization (WHO) has helped to identify the aetiological agent about 1 month after the onset of the epidemic. The power of molecular biology and bioinformatics has enabled the complete decoding of the viral genome within weeks. Over 1000 publications on the phylogeny, epidemiology, genomics, laboratory diagnostics, antiviral, immunization, pathogenesis, clinical disease, and management accumulated within just 1 year. Although the exact animal reservoir of virus and how it evolved into a human pathogen are still obscure, accurate diagnosis and epidemiological control of the disease are now possible. This article reviews what is currently known about the virus and the disease.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16287687      PMCID: PMC7095431          DOI: 10.1080/13550280500187724

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   2.643


  126 in total

1.  Identification of a novel coronavirus in patients with severe acute respiratory syndrome.

Authors:  Christian Drosten; Stephan Günther; Wolfgang Preiser; Sylvie van der Werf; Hans-Reinhard Brodt; Stephan Becker; Holger Rabenau; Marcus Panning; Larissa Kolesnikova; Ron A M Fouchier; Annemarie Berger; Ana-Maria Burguière; Jindrich Cinatl; Markus Eickmann; Nicolas Escriou; Klaus Grywna; Stefanie Kramme; Jean-Claude Manuguerra; Stefanie Müller; Volker Rickerts; Martin Stürmer; Simon Vieth; Hans-Dieter Klenk; Albert D M E Osterhaus; Herbert Schmitz; Hans Wilhelm Doerr
Journal:  N Engl J Med       Date:  2003-04-10       Impact factor: 91.245

2.  Characterization of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) spike glycoprotein-mediated viral entry.

Authors:  Graham Simmons; Jacqueline D Reeves; Andrew J Rennekamp; Sean M Amberg; Andrew J Piefer; Paul Bates
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-09       Impact factor: 11.205

3.  Severe acute respiratory syndrome and the innate immune responses: modulation of effector cell function without productive infection.

Authors:  Chien-Te K Tseng; Lucy A Perrone; Hongbing Zhu; Shinji Makino; Clarence J Peters
Journal:  J Immunol       Date:  2005-06-15       Impact factor: 5.422

4.  Amino acids 270 to 510 of the severe acute respiratory syndrome coronavirus spike protein are required for interaction with receptor.

Authors:  Gregory J Babcock; Diana J Esshaki; William D Thomas; Donna M Ambrosino
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

5.  Discovery of novel human and animal cells infected by the severe acute respiratory syndrome coronavirus by replication-specific multiplex reverse transcription-PCR.

Authors:  Laura Gillim-Ross; Jill Taylor; David R Scholl; Jared Ridenour; Paul S Masters; David E Wentworth
Journal:  J Clin Microbiol       Date:  2004-07       Impact factor: 5.948

6.  Evidence of airborne transmission of the severe acute respiratory syndrome virus.

Authors:  Ignatius T S Yu; Yuguo Li; Tze Wai Wong; Wilson Tam; Andy T Chan; Joseph H W Lee; Dennis Y C Leung; Tommy Ho
Journal:  N Engl J Med       Date:  2004-04-22       Impact factor: 91.245

7.  Analysis of cellular receptors for human coronavirus OC43.

Authors:  C Krempl; B Schultze; G Herrler
Journal:  Adv Exp Med Biol       Date:  1995       Impact factor: 2.622

8.  Identification of an alternative 5'-untranslated exon and new polymorphisms of angiotensin-converting enzyme 2 gene: lack of association with SARS in the Vietnamese population.

Authors:  Satoru Itoyama; Naoto Keicho; Minako Hijikata; Tran Quy; Nguyen Chi Phi; Hoang Thuy Long; Le Dang Ha; Vo Van Ban; Ikumi Matsushita; Hideki Yanai; Fumiko Kirikae; Teruo Kirikae; Tadatoshi Kuratsuji; Takehiko Sasazuki
Journal:  Am J Med Genet A       Date:  2005-07-01       Impact factor: 2.802

9.  Unique and conserved features of genome and proteome of SARS-coronavirus, an early split-off from the coronavirus group 2 lineage.

Authors:  Eric J Snijder; Peter J Bredenbeek; Jessika C Dobbe; Volker Thiel; John Ziebuhr; Leo L M Poon; Yi Guan; Mikhail Rozanov; Willy J M Spaan; Alexander E Gorbalenya
Journal:  J Mol Biol       Date:  2003-08-29       Impact factor: 5.469

10.  Susceptibility of human and rat neural cell lines to infection by SARS-coronavirus.

Authors:  Makiko Yamashita; Masanobu Yamate; Gui-Mei Li; Kazuyoshi Ikuta
Journal:  Biochem Biophys Res Commun       Date:  2005-08-19       Impact factor: 3.322

View more
  6 in total

1.  Altered pathogenesis of porcine respiratory coronavirus in pigs due to immunosuppressive effects of dexamethasone: implications for corticosteroid use in treatment of severe acute respiratory syndrome coronavirus.

Authors:  Kwonil Jung; Konstantin P Alekseev; Xinsheng Zhang; Doo-Sung Cheon; Anastasia N Vlasova; Linda J Saif
Journal:  J Virol       Date:  2007-10-17       Impact factor: 5.103

Review 2.  SARS-CoV-2 and COVID-19: A Narrative Review.

Authors:  A D Blann; R Heitmar
Journal:  Br J Biomed Sci       Date:  2022-09-06       Impact factor: 2.432

3.  Bioaerosol sampling for the detection of aerosolized influenza virus.

Authors:  Francoise M Blachere; William G Lindsley; James E Slaven; Brett J Green; Stacey E Anderson; Bean T Chen; Don H Beezhold
Journal:  Influenza Other Respir Viruses       Date:  2007-05       Impact factor: 4.380

4.  The natural viral load profile of patients with pandemic 2009 influenza A(H1N1) and the effect of oseltamivir treatment.

Authors:  Iris W Li; Ivan F Hung; Kelvin K To; Kwok-Hung Chan; Samson S Y Wong; Jasper F Chan; Vincent C Cheng; Owen T Tsang; Sik-To Lai; Yu-Lung Lau; Kwok-Yung Yuen
Journal:  Chest       Date:  2010-01-08       Impact factor: 9.410

Review 5.  Can the coronavirus infection penetrates the brain resulting in sudden anosmia followed by severe neurological disorders?

Authors:  Mai M Anwar; Ayman M Badawi; Nadia A Eltablawy
Journal:  eNeurologicalSci       Date:  2020-11-11

Review 6.  Antisense technology as a potential strategy for the treatment of coronaviruses infection: With focus on COVID-19.

Authors:  Seyedeh Hoda Alavizadeh; Maham Doagooyan; Fatemeh Zahedipour; Shima Yahoo Torghabe; Bahare Baharieh; Firooze Soleymani; Fatemeh Gheybi
Journal:  IET Nanobiotechnol       Date:  2022-03-10       Impact factor: 1.847

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.